Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ocugen, Inc. Director's Dealing 2021

Dec 18, 2021

32915_dirs_2021-12-17_a62c688c-a965-48fb-bc98-cef67abe7632.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-11-16

Reporting Person: Zhang Junge (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-16 Common Stock X 143820 $2.77 Acquired 875251 Indirect
2021-11-16 Common Stock X 1653 $7.56 Acquired 876904 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-16 Warrants (Right to Buy) $2.77 X 143820 Disposed 2026-11-18 Common Stock (143820) Indirect
2021-11-16 Warrants (Right to Buy) $7.56 X 1653 Disposed 2027-06-17 Common Stock (1653) Indirect

Footnotes

F1: This Form 4 is being filed late due to an administrative error.